Allosteric regulation of G protein-coupled receptor activity by phospholipids

被引:0
|
作者
Dawaliby R. [1 ]
Trubbia C. [1 ]
Delporte C. [2 ,3 ]
Masureel M. [4 ]
Van Antwerpen P. [2 ,3 ]
Kobilka B.K. [4 ]
Govaerts C. [1 ]
机构
[1] Laboratory for the Structure and Function of Biological Membranes, Center for Structural Biology and Bioinformatics, Université Libre de Bruxelles, Brussels
[2] Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, Université Libre de Bruxelles, Brussels
[3] Analytical Platform of the Faculty of Pharmacy, Faculty of Pharmacy, Université Libre de Bruxelles, Brussels
[4] Department of Molecular and Cellular Physiology, Stanford University, School of Medicine, Stanford, CA
关键词
D O I
10.1038/nchembio.1960
中图分类号
学科分类号
摘要
Lipids are emerging as key regulators of membrane protein structure and activity. These effects can be attributed either to the modification of bilayer properties (thickness, curvature and surface tension) or to the binding of specific lipids to the protein surface. For G protein-coupled receptors (GPCRs), the effects of phospholipids on receptor structure and activity remain poorly understood. Here we reconstituted purified β2-adrenergic receptor (β2R) in high-density lipoparticles to systematically characterize the effect of biologically relevant phospholipids on receptor activity. We observed that the lipid headgroup type affected ligand binding (agonist and antagonist) and receptor activation. Specifically, phosphatidylgycerol markedly favored agonist binding and facilitated receptor activation, whereas phosphatidylethanolamine favored antagonist binding and stabilized the inactive state of the receptor. We then showed that these effects could be recapitulated with detergent-solubilized lipids, demonstrating that the functional modulation occurred in the absence of a bilayer. Our data suggest that phospholipids act as direct allosteric modulators of GPCR activity. © 2015 Nature America, Inc. All rights reserved.
引用
收藏
页码:35 / 39
页数:4
相关论文
共 50 条
  • [1] Allosteric regulation of G protein-coupled receptor activity by phospholipids
    Dawaliby, Rosie
    Trubbia, Cataldo
    Delporte, Cedric
    Masureel, Matthieu
    Van Antwerpen, Pierre
    Kobilka, Brian K.
    Govaerts, Cedric
    NATURE CHEMICAL BIOLOGY, 2016, 12 (01) : 35 - +
  • [2] Regulation of G Protein-Coupled Receptor Kinases by Phospholipids
    Homan, K. T.
    Glukhova, A.
    Tesmer, J. J. G.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (01) : 39 - 46
  • [3] Regulation of G Protein-Coupled Receptors by Allosteric Ligands
    Lane, J. Robert
    Abdul-Ridha, Alaa
    Canals, Meritxell
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (04): : 527 - 534
  • [4] Allosteric properties of G protein-coupled receptor oligomers
    Springael, Jean-Yves
    Urizar, Eneko
    Costagliola, Sabine
    Vassart, Gilbert
    Parmentier, Marc
    PHARMACOLOGY & THERAPEUTICS, 2007, 115 (03) : 410 - 418
  • [5] Allosteric modulation of G protein-coupled receptor signaling
    Shen, Siyuan
    Zhao, Chang
    Wu, Chao
    Sun, Suyue
    Li, Ziyan
    Yan, Wei
    Shao, Zhenhua
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] Allosteric and biased G protein-coupled receptor signaling regulation: potentials for new therapeutics
    Khoury, Etienne
    Clement, Stephanie
    Laporte, Stephane A.
    FRONTIERS IN ENDOCRINOLOGY, 2014, 5
  • [7] Regulation of G protein-coupled receptor trafficking
    Xu, Z. -Q. D.
    Zhang, X.
    Scott, L.
    ACTA PHYSIOLOGICA, 2007, 190 (01) : 39 - 45
  • [8] Selective Photoswitchable Allosteric Agonist of a G Protein-Coupled Receptor
    Donthamsetti, Prashant
    Konrad, David B.
    Hetzler, Belinda
    Fu, Zhu
    Trauner, Dirk
    Isacoff, Ehud Y.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2021, 143 (24) : 8951 - 8956
  • [9] Regulation of G protein-coupled receptor kinases
    Penn, RB
    Pronin, AN
    Benovic, JL
    TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (02) : 81 - 89
  • [10] Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
    Abdul-Ridha, Alaa
    Lane, J. Robert
    Sexton, Patrick M.
    Canals, Meritxell
    Christopoulos, Arthur
    MOLECULAR PHARMACOLOGY, 2013, 83 (02) : 521 - 530